Lundorff, MD, L., Sjøgren, DmSci, MD, P., Hansen, MD, O. B., Jonsson, MD, T., Nielsen, P. R., & Christrup, PhD, MSc(Pharm), L. (2013). Switching from high doses of pure µ-opioid agonists to transdermal buprenorphine in patients with cancer: A feasibility study. Journal of Opioid Management, 9(4), 255–262. https://doi.org/10.5055/jom.2013.0166